Neuromuscular Research Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
J Neurol Sci. 2018 Apr 15;387:134-138. doi: 10.1016/j.jns.2018.02.021. Epub 2018 Feb 7.
PHARC (Polyneuropathy, Hearing loss, Ataxia, Retinitis pigmentosa and Cataracts) (MIM# 612674) is an autosomal recessive neurodegenerative disease caused by mutations in the ABHD12 gene. We evaluated two Spanish siblings affected with pes cavus, sensorimotor neuropathy, hearing loss, retinitis pigmentosa and juvenile cataracts in whom the genetic test of ABHD12 revealed a novel homozygous frameshift mutation, c.211_223del (p.Arg71Tyrfs*26). The earliest clinical manifestation in these patients was a demyelinating neuropathy manifested with a Charcot-Marie-Tooth phenotype over three decades. Progressive hearing loss, cataracts and retinitis pigmentosa appeared after the age of 30. We herein describe the complete clinical picture of these two patients, and focus particularly on neuropathy characteristics. This study supports the fact that although PHARC is rare, its phenotype is very characteristic and we should include its study in patients affected with demyelinating polyneuropathy, hearing loss and retinopathy.
PHARC(多发性神经病、听力损失、共济失调、视网膜色素变性和白内障)(MIM#612674)是一种常染色体隐性神经退行性疾病,由 ABHD12 基因突变引起。我们评估了两名受影响的西班牙兄弟姐妹,他们患有高弓足、感觉运动神经病、听力损失、视网膜色素变性和青少年白内障,ABHD12 的基因检测显示一种新的纯合移码突变,c.211_223del(p.Arg71Tyrfs*26)。这些患者最早的临床表现是脱髓鞘神经病,表现为 30 多年前的 Charcot-Marie-Tooth 表型。进行性听力损失、白内障和视网膜色素变性在 30 岁后出现。我们在此描述了这两名患者的完整临床表现,特别关注神经病学特征。本研究支持这样一个事实,即尽管 PHARC 很罕见,但它的表型非常特征,我们应该在患有脱髓鞘多发性神经病、听力损失和视网膜病变的患者中研究它。